A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.

A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
复制标题

DOI:
10.1242/dmm.007401
复制
发表时间:
2012-01
影响因子:
4.3
通讯作者:
Amatruda JF
Amatruda JF
中科院分区:
医学2区
文献类型:
--
作者:
Leacock SW;Basse AN;Chandler GL;Kirk AM;Rakheja D;Amatruda JF

文献摘要

参考文献

被引文献

相似文献

Ewing’s sarcoma, a malignant bone tumor of children and young adults, is a member of the small-round-blue-cell tumor family. Ewing’s sarcoma family tumors (ESFTs), which include peripheral primitive neuroectodermal tumors (PNETs), are characterized by chromosomal translocations that generate fusions between the EWS gene and ETS-family transcription factors, most commonly FLI1. The EWS-FLI1 fusion oncoprotein represents an attractive therapeutic target for treatment of Ewing’s sarcoma. The cell of origin of ESFT and the molecular mechanisms by which EWS-FLI1 mediates tumorigenesis remain unknown, and few animal models of Ewing’s sarcoma exist. Here, we report the use of zebrafish as a vertebrate model of EWS-FLI1 function and tumorigenesis. Mosaic expression of the human EWS-FLI1 fusion protein in zebrafish caused the development of tumors with histology strongly resembling that of human Ewing’s sarcoma. The incidence of tumors increased in a p53 mutant background, suggesting that the p53 pathway suppresses EWS-FLI1-driven tumorigenesis. Gene expression profiling of the zebrafish tumors defined a set of genes that might be regulated by EWS-FLI1, including the zebrafish ortholog of a crucial EWS-FLI1 target gene in humans. Stable zebrafish transgenic lines expressing EWS-FLI1 under the control of the heat-shock promoter exhibit altered embryonic development and defective convergence and extension, suggesting that EWS-FLI1 interacts with conserved developmental pathways. These results indicate that functional targets of EWS-FLI1 that mediate tumorigenesis are conserved from zebrafish to human and provide a novel context in which to study the function of this fusion oncogene.
DOI: 10.1016/j.bbcan.2009.04.005
发表时间: 2009-12
影响因子: 11.2
作者:
Brenner, J. Chad;Chinnaiyan, Arul M.
通讯作者: Chinnaiyan, Arul M.
DOI: 10.1038/sj.leu.2404546
发表时间: 2007-03-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Chen, J.;Jette, C.;Griffin, J. D.
通讯作者: Griffin, J. D.
DOI: 10.1002/ijc.2910570308
发表时间: 1994-05-01
影响因子: 6.4
作者:
HAMELIN, R;ZUCMAN, J;THOMAS, G
通讯作者: THOMAS, G
DOI: 10.1158/0008-5472.can-05-1699
发表时间: 2005-10-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Baird, K;Davis, S;Meltzer, PS
通讯作者: Meltzer, PS
DOI: 10.1038/leu.2009.116
发表时间: 2009-10-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Frazer, J. K.;Meeker, N. D.;Trede, N. S.
通讯作者: Trede, N. S.